Page last updated: 2024-10-31

methocarbamol and Musculoskeletal Diseases

methocarbamol has been researched along with Musculoskeletal Diseases in 1 studies

Methocarbamol: A centrally acting muscle relaxant whose mode of action has not been established. It is used as an adjunct in the symptomatic treatment of musculoskeletal conditions associated with painful muscle spasm. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1206)
methocarbamol : A racemate comprising equimolar amounts of (R)- and (S)-methocarbamol. A centrally acting skeletal muscle relaxant, it is used as an adjunct in the short-term symptomatic treatment of painful muscle spasm. The (R)-enantiomer is more active than the (S)-enantiomer.
2-hydroxy-3-(2-methoxyphenoxy)propyl carbamate : A carbamate ester that is glycerol in which one of the primary alcohol groups has been converted to its 2-methoxyphenyl ether while the other has been converted to the corresponding carbamate ester.

Musculoskeletal Diseases: Diseases of the muscles and their associated ligaments and other connective tissue and of the bones and cartilage viewed collectively.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
FLINCHUM, D1

Other Studies

1 other study available for methocarbamol and Musculoskeletal Diseases

ArticleYear
Musculoskeletal disorders amenable to treatment with intravenous methocarbamol.
    Clinical medicine (Northfield, Ill.), 1961, Volume: 8

    Topics: Disease; Methocarbamol; Muscle Relaxants, Central; Muscles; Muscular Diseases; Musculoskeletal Disea

1961